Trevi Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Trevi Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2018 to Q4 2024.
  • Trevi Therapeutics, Inc. Operating Lease, Payments for the quarter ending December 31, 2024 was $87K, a 26.1% increase year-over-year.
  • Trevi Therapeutics, Inc. Operating Lease, Payments for the twelve months ending December 31, 2024 was $303K, a 31.2% increase year-over-year.
  • Trevi Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $303K, a 31.2% increase from 2023.
  • Trevi Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $231K, a 77.7% increase from 2022.
  • Trevi Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $130K, a 6.48% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.